Clinical Trial

Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis

Study acronym: REALPASS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the clinical investigation is to characterize clinical outcomes and to assess the real-world use of the commercial PALMAZ MULLINS XD™ Pulmonary Stent.
Trial Details
NCT Number NCT07122518
Lead Sponsor Cordis US Corp.
Collaborators: Congenital Cardiovascular Interventional Study Consortium (CCISC)
Conditions Pulmonary Artery Stenosis
Enrollment 75 participants
Start Date 2025-12
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-14